Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,74 USD | +2,35% | +10,13% | +13,73% |
Attività
Numero di dipendenti: 285
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +766,19% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +766,19% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Lonnel Coats
CEO | Chief Executive Officer | 58 | 07/07/14 |
Jeffrey Wade
DFI | Director of Finance/CFO | 59 | 01/01/99 |
Craig Granowitz
CTO | Chief Tech/Sci/R&D Officer | 60 | 02/08/21 |
Investor Relations Contact | 45 | 13/11 | |
Tom Garner
PRN | Corporate Officer/Principal | - | 09/10/23 |
Wendy Mcdermott
HRO | Human Resources Officer | - | 01/01/22 |
Comptroller/Controller/Auditor | 56 | 01/06/17 | |
General Counsel | - | 04/11/14 | |
Brian Crum
LAW | General Counsel | 51 | 01/01/01 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Robert Lefkowitz
BRD | Director/Board Member | 80 | 01/02/01 |
Ray Debbane
CHM | Chairman | 69 | 01/08/07 |
Director/Board Member | 65 | 28/08/07 | |
Philippe Amouyal
BRD | Director/Board Member | 65 | 01/08/07 |
Judith Swain
BRD | Director/Board Member | 75 | 01/09/07 |
Lonnel Coats
CEO | Chief Executive Officer | 58 | 07/07/14 |
Samuel Barker
BRD | Director/Board Member | 81 | 01/03/00 |
Diane Sullivan
BRD | Director/Board Member | 62 | 28/07/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 247 764 761 | 242 087 491 ( 97,71 %) | 1 528 008 ( 0,6167 %) | 97,71 % |
Coordinate società
Lexicon Pharmaceuticals, Inc.
2445 Technology Forest Boulevard 11th floor
77381-1160, The Woodlands
+
http://www.lexpharma.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+13,73% | 428 Mln | |
-1,43% | 104 Mrd | |
+8,96% | 105 Mrd | |
+4,40% | 22,94 Mrd | |
-12,15% | 22,34 Mrd | |
-4,36% | 19,25 Mrd | |
-39,98% | 17,08 Mrd | |
-10,04% | 16,96 Mrd | |
+6,79% | 14,16 Mrd | |
+38,61% | 12,63 Mrd |
- Borsa valori
- Azioni
- Azione LXRX
- Società Lexicon Pharmaceuticals, Inc.